Buyout (LBO, MBO, MBI) • Manufacturing

Edmond de Rothschild Private Equity Acquires Rossignol

On May 1, 2009, private equity firm Edmond de Rothschild Private Equity acquired manufacturer Rossignol

Acquisition Context
  • This is Edmond de Rothschild Private Equity’s 1st transaction in the Manufacturing sector.
  • This is Edmond de Rothschild Private Equity’s 10th transaction in France.
Investment Fate
  • Rossignol was sold to a consortium of financial buyers in 2012.
  • Rossignol was sold to a consortium of financial buyers in 2021.

Explore All 1609 Buyout (LBO, MBO, MBI) Manufacturing Deals - Search the Database Free


M&A Deal Summary

Date May 1, 2009
Target Rossignol
Sector Manufacturing
Buyer(s) Edmond de Rothschild Private Equity
Deal Type Buyout (LBO, MBO, MBI)

Target Company

Rossignol

Montsurs, France
Rossignol is a manufacturer, designer, and distributor of waste collection and hygiene equipment come in a range of colors and sizes, transforming this every-day object into a decorative kitchen article. Rossignol was founded in 1896 and is based in Montsurs, France.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

DESCRIPTION

Edmond de Rothschild Private Equity is the private equity arm of asset manager and financial services firm Edmond de Rothschild. The private equity group looks seeks buyout and expansion style investments and will consider opportunities across the world, including North America, Europe, and Africa. The Firm broadly invests in real estate, infrastructure projects, and directly in companies. Edmond de Rothschild Private Equity is based in Geneva, Switzerland.


Deal Context for Buyer #
Overall 11 of 31
Sector: Manufacturing 1 of 2
Type: Buyout (LBO, MBO, MBI) 5 of 9
Country: France 10 of 22
Year: 2009 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-03-05 GlycoVaxyn AG

Schlieren, Switzerland

GlycoVaxyn AG is a specialist vaccine biopharmaceutical company.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-01 Regado Biosciences

Basking Ridge, New Jersey, United States

Regado Biosciences, Inc. is a developer of antithrombotic therapeutic aptamers with active control agents.

Buy -